Research Topics
| Koen Van HerckSummaryAffiliation: University of Antwerp Country: Belgium Publications
| Collaborators
|
Detail Information
Publications
A review of the long-term protection after hepatitis A and B vaccinationPierre Van Damme
Centre for the Evaluation of Vaccination, WHO Collaborating Centre for Prevention and Control of Viral Hepatitis, Department of Epidemiology and Social Medicine, University of Antwerp, Belgium
Travel Med Infect Dis 5:79-84. 2007....
Cost-effectiveness analysis of malaria chemoprophylaxis for travellers to West-AfricaLukas L Widmer
University of Zurich Centre for Travel Medicine, WHO Collaborating Centre for Travellers Health, Hirschengraben 84, 8001 Zurich, Switzerland
BMC Infect Dis 10:279. 2010....
Prevention of viral hepatitis (B and C) reassessedKoen Van Herck
Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium
Best Pract Res Clin Gastroenterol 22:1009-29. 2008..Despite important efforts, transmission in injecting drug users is increasing...- Prevention of hepatitis A by Havrix: a reviewKoen Van Herck
Centre for the Evaluation of Vaccination, WHO Collaborating Centre for the Prevention and Control of Viral Hepatitis, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium
Expert Rev Vaccines 4:459-71. 2005..In view of this, current regulatory recommendations for the use of hepatitis A vaccines are reviewed and possible future strategies identified... - Hepatitis A vaccine: indirect evidence of immune memory 12 years after the primary courseKoen Van Herck
Centre for the Evaluation of Vaccination, University of Antwerp, Belgium
J Med Virol 72:194-6. 2004..This study shows a substantial immune response to re-exposure to hepatitis A antigen after 12 years, which occurs rapidly to ensure protection within the average incubation period of hepatitis A virus... - Ten-year antibody persistence induced by hepatitis A and B vaccine (Twinrix) in adultsK Van Herck
Centre for the Evaluation of Vaccination, WHO Collaborating Centre for Prevention and Control of Viral Hepatitis, Unit of Epidemiology and Social Medicine, University of Antwerp Campus Drie Eiken, Wilrijk, Belgium
Travel Med Infect Dis 5:171-5. 2007..Hepatitis A and B infections are prevalent worldwide and cause significant morbidity and mortality. A combined vaccine providing dual protection against hepatitis A and B is available (Twinrix, GlaxoSmithKline Biologicals)... - Schedules for hepatitis B vaccination of risk groups: balancing immunogenicity and complianceK Van Herck
Centre for the Evaluation of Vaccination, WHO Collaborating Centre for Prevention and Control of Viral Hepatitis, Department Epidemiology and Social Medicine, University of Antwerp, Campus Drie Eiken, Antwerp, Belgium
Sex Transm Infect 83:426-32. 2007..Vaccination is an important tool in hepatitis B prevention. However, several vaccine doses are required to induce long-term protection. Several at-risk groups have difficulties in adhering to the standard vaccination schedule... - Benefits of early hepatitis B immunization programs for newborns and infantsKoen Van Herck
WHO Collaborating Centre for Prevention and Control of Viral Hepatitis, Vaccine, and Infectious Disease Institute, University of Antwerp, Belgium
Pediatr Infect Dis J 27:861-9. 2008.... - Knowledge, attitudes and practices in travel-related infectious diseases: the European airport surveyKoen Van Herck
WHO Collaborating Centre for Prevention and Control of Viral Hepatitis, Unit of Epidemiology and Social Medicine, University of Antwerp, Antwerp, Belgium
J Travel Med 11:3-8. 2004..Our common objective is to help travelers stay healthy while abroad, and consequently to also reduce the potential importation of infectious diseases and the consequent public health and other implications... - A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccinePierre Van Damme
Unit of Epidemiology and Social Medicine, Centre for the Evaluation of Vaccination, WHO Collaborating Centre for the Prevention and Control of Viral Hepatitis, University of Antwerp, Campus 3 Eiken, Wilrijk, Belgium
Expert Rev Vaccines 3:249-67. 2004..This paper provides a critical review of clinical data on the efficacy, immunogenicity and tolerability of the combined vaccine, with particular focus on the clinical benefits of dual vaccination... - Effectiveness of rotavirus vaccination in prevention of hospital admissions for rotavirus gastroenteritis among young children in Belgium: case-control studyTessa Braeckman
Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium
BMJ 345:e4752. 2012..To evaluate the effectiveness of rotavirus vaccination among young children in Belgium... - Two decades of hepatitis B vaccination in mentally retarded patients: effectiveness, antibody persistence and duration of immune memoryTessa Braeckman
Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1, 2610 Antwerpen Wilrijk, Belgium
Vaccine 30:4757-61. 2012..We studied the persistence of vaccine-induced anti-HBs antibodies and the robustness of the HBsAg-specific immune memory in this population, 18-20 years after the first vaccine dose... - Do we need hepatitis A booster vaccinations?Pierre A Van Damme
Center for the Evaluation of Vaccination, Epidemiology and Social Medicine, University of Antwerp, Campus Drie Eiken, Universiteitsplein 1, 2610 Wilrijk, Belgium
J Travel Med 11:179-80. 2004 - Antibody persistence and immune memory in healthy adults following vaccination with a two-dose inactivated hepatitis A vaccine: long-term follow-up at 15 yearsKoen Van Herck
Centre for the Evaluation of Vaccination WHO Collaborating Centre, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium
J Med Virol 83:1885-91. 2011..No difference in long-term antibody persistence was observed between the two primary vaccination schedules, reinforcing the potential for flexibility in the timing of the second primary vaccine dose... - Seventeen-year antibody persistence in adults primed with two doses of an inactivated hepatitis A vaccineKoen Van Herck
Vaccine and Infectious Disease Institute WHO Collaborating Centre, Centre for the Evaluation of Vaccination, Antwerpen, Belgium
Hum Vaccin Immunother 8:323-7. 2012..This communication provides additional information on antibody persistence up to Year 17 from two of the longest follow-up studies [NCT00289757/NCT00291876]... - Macrolide- and telithromycin-resistant Streptococcus pyogenes, Belgium, 1999-2003Surbhi Malhotra-Kumar
University of Antwerp, Antwerp, Belgium
Emerg Infect Dis 11:939-42. 2005..We also report one of the largest collections of telithromycin-resistant isolates... - Lessons learned from a measles outbreak in Antwerp, Belgium 2007-2008Carine Asnong
School Health Center of the Province of Antwerp, Antwerp, Belgium
Pediatr Infect Dis J 30:343-5. 2011..Not only belief issues but difficulties to access the regular vaccination program also seem to be the main reason... - Rotavirus vaccines in Belgium: policy and impactTessa Braeckman
Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium
Pediatr Infect Dis J 30:S21-4. 2011..Shortly after introduction, a nation-wide recommendation was issued and despite the fact that both rotavirus vaccines are offered through partial reimbursement, vaccine uptake has already reached a high level (at least 90%)... - Travelers' knowledge, attitudes, and practices on prevention of infectious diseases: results from a pilot studyKoen Van Herck
Centre for the Evaluation of Vaccination, WHO Collaborating Centre for Prevention and Control of Viral Hepatitis Epidemiology and Social Medicine, University of Antwerp, Universiteitsplein 1, B-2610 Antwerp, Belgium
J Travel Med 10:75-8. 2003..Strategies are needed for raising awareness of preventable travel health issues and for raising compliance with existing recommendations... - Seroprevalence of Bordetella pertussis antibodies in Flanders (Belgium)Marie Van der Wielen
Department of Epidemiology and Social Medicine, WHO Collaborating Centre for Prevention and Control of Viral Hepatitis, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium
Vaccine 21:2412-7. 2003..These data confirm waning of vaccine-induced antibody levels and suggest pertussis resurgence during adolescence and young adulthood. These results support a pertussis booster vaccination policy for adolescents and adults... - Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled studySurbhi Malhotra Kumar
Department of Medical Microbiology, University of Antwerp, Belgium
Lancet 369:482-90. 2007..We used the macrolides azithromycin and clarithromycin to investigate the direct effect of antibiotic exposure on resistance in the oral streptococcal flora of healthy volunteers... - Effect of hepatitis A vaccination programsPierre Van Damme
JAMA 294:246-8. 2005 - Hepatitis A vaccineKoen Van Herck
N Engl J Med 350:2211-2; author reply 2211-2. 2004 - Combined hepatitis A and B vaccine in elderlyPierre Van Damme
Vaccine 22:303-4. 2004 - Rapid protection and vaccination against hepatitis A for travellersBradley A Connor
The New York Center for Travel and Tropical Medicine, New York, NY 10021, USA
BioDrugs 17:19-21. 2003